Effect of Study Design on Sample Size in Studies Intended to Evaluate Bioequivalence of Inhaled Short‐Acting β‐Agonist Formulations

Tekijä Zeng, Yaohui, Singh, Sachinkumar, Wang, Kai, Ahrens, Richard C.
Julkaisussa J Clin Pharmacol (2017)

Efficacy and safety of a unique enteric-coated bicarbonate-buffered pancreatic enzyme replacement therapy in children and adults with cystic fibrosis

Tekijä Konstan, Michael W, Accurso, Frank J, Nasr, Samya Z, Ahrens, Richard C, Graff, Gavin R
Julkaistu 2013

Intersession Variability in Single-Breath Diffusing Capacity in Diabetics without Overt Lung Disease

Tekijä Drummond, Michael B., Schwartz, Pamela F., Duggan, William T., Teeter, John G., Riese, Richard J., Ahrens, Richard C., Crapo, Robert O., England, Richard D., MacIntyre, Neil R., Jensen, Robert L., Wise, Robert A.
Julkaistu 2008

Airway microbiota across age and disease spectrum in cystic fibrosis

Tekijä Zemanick, Edith T., Wagner, Brandie D., Robertson, Charles E., Ahrens, Richard C., Chmiel, James F., Clancy, John P., Gibson, Ronald L., Harris, William T., Kurland, Geoffrey, Laguna, Theresa A., McColley, Susanna A., McCoy, Karen, Retsch-Bogart, George, Sobush, Kurtis T., Zeitlin, Pamela L., Stevens, Mark J., Accurso, Frank J., Sagel, Scott D., Harris, J. Kirk
Julkaisussa Eur Respir J (2017)